Janet Wenzlau
Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cation Transport Proteins | 25 | 2015 | 134 | 3.950 |
Why?
| | Autoantibodies | 39 | 2025 | 1501 | 3.390 |
Why?
| | Diabetes Mellitus, Type 1 | 42 | 2025 | 3708 | 2.850 |
Why?
| | H(+)-K(+)-Exchanging ATPase | 7 | 2020 | 15 | 1.580 |
Why?
| | Autoantigens | 9 | 2025 | 429 | 1.240 |
Why?
| | Zinc Transporter 8 | 24 | 2021 | 87 | 1.230 |
Why?
| | Islets of Langerhans | 7 | 2024 | 803 | 0.910 |
Why?
| | Insulin-Secreting Cells | 3 | 2024 | 372 | 0.790 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 8 | 2025 | 63 | 0.730 |
Why?
| | Parietal Cells, Gastric | 3 | 2020 | 5 | 0.670 |
Why?
| | Autoimmunity | 8 | 2018 | 907 | 0.610 |
Why?
| | Mice, Inbred NOD | 5 | 2024 | 601 | 0.610 |
Why?
| | Epitopes | 5 | 2025 | 481 | 0.570 |
Why?
| | Gastritis, Atrophic | 2 | 2020 | 6 | 0.550 |
Why?
| | Prediabetic State | 5 | 2013 | 252 | 0.540 |
Why?
| | Protein Subunits | 2 | 2011 | 238 | 0.400 |
Why?
| | Antibody Formation | 2 | 2008 | 299 | 0.340 |
Why?
| | Glutamate Decarboxylase | 6 | 2018 | 170 | 0.330 |
Why?
| | Antigens | 3 | 2024 | 358 | 0.330 |
Why?
| | Epitope Mapping | 2 | 2008 | 62 | 0.320 |
Why?
| | Child, Preschool | 20 | 2025 | 11097 | 0.320 |
Why?
| | Peptides | 3 | 2024 | 986 | 0.300 |
Why?
| | Insulin Antibodies | 3 | 2015 | 105 | 0.300 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2015 | 2193 | 0.290 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2006 | 446 | 0.290 |
Why?
| | Young Adult | 21 | 2025 | 13243 | 0.280 |
Why?
| | Adolescent | 27 | 2025 | 21555 | 0.280 |
Why?
| | Mice | 9 | 2024 | 17843 | 0.270 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2006 | 260 | 0.260 |
Why?
| | Child | 26 | 2025 | 22037 | 0.260 |
Why?
| | Acetyltransferases | 1 | 2006 | 22 | 0.250 |
Why?
| | Animals | 16 | 2024 | 37011 | 0.250 |
Why?
| | Infant | 14 | 2021 | 9467 | 0.240 |
Why?
| | Helicobacter Infections | 2 | 2016 | 32 | 0.230 |
Why?
| | Embryonic Development | 1 | 2006 | 118 | 0.230 |
Why?
| | Antibody Specificity | 4 | 2008 | 189 | 0.230 |
Why?
| | Humans | 45 | 2025 | 137514 | 0.220 |
Why?
| | HLA-A24 Antigen | 2 | 2013 | 6 | 0.210 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2025 | 1092 | 0.190 |
Why?
| | Male | 30 | 2025 | 67718 | 0.180 |
Why?
| | Autoimmune Diseases | 3 | 2016 | 459 | 0.180 |
Why?
| | Zebrafish | 1 | 2006 | 496 | 0.180 |
Why?
| | Age Distribution | 2 | 2015 | 391 | 0.180 |
Why?
| | Female | 30 | 2025 | 73162 | 0.180 |
Why?
| | Luciferases | 2 | 2019 | 151 | 0.170 |
Why?
| | Immunoprecipitation | 2 | 2019 | 155 | 0.170 |
Why?
| | Iodide Peroxidase | 2 | 2018 | 28 | 0.170 |
Why?
| | Adult | 21 | 2025 | 37821 | 0.170 |
Why?
| | Genetic Predisposition to Disease | 5 | 2018 | 2420 | 0.170 |
Why?
| | Prevalence | 3 | 2015 | 2719 | 0.160 |
Why?
| | Genes, Fungal | 2 | 1990 | 53 | 0.160 |
Why?
| | Radioimmunoassay | 3 | 2018 | 174 | 0.160 |
Why?
| | Proteins | 1 | 2006 | 1012 | 0.160 |
Why?
| | Biomarkers | 6 | 2020 | 4172 | 0.160 |
Why?
| | Transglutaminases | 2 | 2018 | 156 | 0.160 |
Why?
| | Seroepidemiologic Studies | 2 | 2010 | 163 | 0.160 |
Why?
| | HLA-DQ Antigens | 3 | 2018 | 181 | 0.150 |
Why?
| | Haplotypes | 3 | 2015 | 491 | 0.150 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2020 | 187 | 0.150 |
Why?
| | Protein Kinases | 3 | 2006 | 319 | 0.150 |
Why?
| | Peptide Fragments | 1 | 2022 | 708 | 0.150 |
Why?
| | Iron-Binding Proteins | 1 | 2018 | 44 | 0.140 |
Why?
| | HLA-DRB1 Chains | 2 | 2015 | 112 | 0.140 |
Why?
| | T-Lymphocytes | 2 | 2020 | 1999 | 0.140 |
Why?
| | GTP-Binding Proteins | 1 | 2018 | 163 | 0.140 |
Why?
| | Age of Onset | 2 | 2010 | 522 | 0.140 |
Why?
| | Case-Control Studies | 7 | 2020 | 3546 | 0.130 |
Why?
| | Genetic Association Studies | 2 | 2015 | 377 | 0.130 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2008 | 765 | 0.120 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2015 | 46 | 0.120 |
Why?
| | Middle Aged | 11 | 2021 | 33355 | 0.120 |
Why?
| | Genotype | 5 | 2015 | 1920 | 0.120 |
Why?
| | Protein Tyrosine Phosphatases | 2 | 2008 | 171 | 0.120 |
Why?
| | HLA-DP beta-Chains | 1 | 2015 | 85 | 0.120 |
Why?
| | CTLA-4 Antigen | 1 | 2015 | 99 | 0.120 |
Why?
| | Saccharomyces cerevisiae | 2 | 1990 | 562 | 0.120 |
Why?
| | Linkage Disequilibrium | 1 | 2015 | 268 | 0.120 |
Why?
| | Alleles | 2 | 2015 | 891 | 0.110 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2004 | 35 | 0.110 |
Why?
| | Helicobacter pylori | 1 | 2014 | 42 | 0.110 |
Why?
| | Gene Frequency | 1 | 2015 | 521 | 0.110 |
Why?
| | HLA Antigens | 1 | 2015 | 237 | 0.110 |
Why?
| | HLA-B18 Antigen | 1 | 2013 | 1 | 0.110 |
Why?
| | HLA-B39 Antigen | 1 | 2013 | 1 | 0.110 |
Why?
| | Genetic Loci | 1 | 2015 | 288 | 0.100 |
Why?
| | Insulin | 8 | 2022 | 2398 | 0.100 |
Why?
| | Sensitivity and Specificity | 4 | 2013 | 1950 | 0.100 |
Why?
| | Proinsulin | 1 | 2013 | 52 | 0.100 |
Why?
| | Diabetes Mellitus | 2 | 2012 | 1035 | 0.100 |
Why?
| | Steroid 21-Hydroxylase | 1 | 2012 | 30 | 0.100 |
Why?
| | Proto-Oncogene Proteins | 3 | 2004 | 646 | 0.100 |
Why?
| | Stomach | 1 | 2012 | 110 | 0.100 |
Why?
| | DNA, Mitochondrial | 2 | 1990 | 201 | 0.090 |
Why?
| | Anemia, Pernicious | 1 | 2011 | 9 | 0.090 |
Why?
| | Cell Differentiation | 1 | 2020 | 1979 | 0.090 |
Why?
| | DNA Probes | 1 | 2011 | 60 | 0.090 |
Why?
| | Laboratory Proficiency Testing | 1 | 2011 | 10 | 0.090 |
Why?
| | Introns | 2 | 1990 | 256 | 0.090 |
Why?
| | Polymorphism, Genetic | 2 | 2011 | 658 | 0.090 |
Why?
| | Immunoassay | 1 | 2011 | 114 | 0.090 |
Why?
| | Aged | 7 | 2021 | 23798 | 0.090 |
Why?
| | Infant, Newborn | 4 | 2015 | 6059 | 0.090 |
Why?
| | Arginine | 2 | 2008 | 274 | 0.080 |
Why?
| | HLA-DR3 Antigen | 3 | 2018 | 80 | 0.080 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2015 | 807 | 0.080 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 849 | 0.080 |
Why?
| | Zinc | 2 | 2009 | 298 | 0.080 |
Why?
| | Nucleotidyltransferases | 1 | 1989 | 28 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2014 | 2521 | 0.070 |
Why?
| | Endoribonucleases | 1 | 1989 | 80 | 0.070 |
Why?
| | Protein Conformation | 1 | 2011 | 930 | 0.070 |
Why?
| | Cell Division | 3 | 2004 | 795 | 0.070 |
Why?
| | Conserved Sequence | 1 | 2008 | 239 | 0.070 |
Why?
| | TOR Serine-Threonine Kinases | 3 | 2006 | 414 | 0.070 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2008 | 377 | 0.070 |
Why?
| | Down-Regulation | 1 | 2010 | 658 | 0.070 |
Why?
| | Protein Processing, Post-Translational | 3 | 2025 | 471 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2008 | 4206 | 0.070 |
Why?
| | Organ Specificity | 1 | 2007 | 304 | 0.070 |
Why?
| | Kinetics | 1 | 2010 | 1679 | 0.070 |
Why?
| | Cross-Sectional Studies | 3 | 2015 | 5427 | 0.060 |
Why?
| | Polymerase Chain Reaction | 2 | 2008 | 1061 | 0.060 |
Why?
| | Time Factors | 3 | 2015 | 6817 | 0.060 |
Why?
| | Protein Structure, Tertiary | 1 | 2008 | 869 | 0.060 |
Why?
| | Phosphatidylinositol 3-Kinases | 2 | 2004 | 366 | 0.060 |
Why?
| | Acetylation | 1 | 2006 | 254 | 0.060 |
Why?
| | Animals, Genetically Modified | 1 | 2006 | 241 | 0.060 |
Why?
| | Disease Progression | 1 | 2013 | 2755 | 0.060 |
Why?
| | Prognosis | 2 | 2015 | 4031 | 0.060 |
Why?
| | Ribosomal Protein S6 | 1 | 2004 | 15 | 0.060 |
Why?
| | Heparan Sulfate Proteoglycans | 1 | 2003 | 26 | 0.050 |
Why?
| | Tunica Intima | 1 | 2004 | 84 | 0.050 |
Why?
| | Belgium | 2 | 2013 | 12 | 0.050 |
Why?
| | Mice, Transgenic | 1 | 2008 | 2182 | 0.050 |
Why?
| | Cathepsin D | 1 | 2022 | 18 | 0.050 |
Why?
| | Insulin, Regular, Human | 1 | 2022 | 43 | 0.050 |
Why?
| | Cohort Studies | 4 | 2017 | 5730 | 0.050 |
Why?
| | Protein Biosynthesis | 2 | 2019 | 434 | 0.050 |
Why?
| | Cystic Fibrosis | 1 | 2012 | 1105 | 0.050 |
Why?
| | Adenosine Triphosphate | 1 | 2004 | 487 | 0.050 |
Why?
| | HLA-DR4 Antigen | 2 | 2012 | 78 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2008 | 1770 | 0.050 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 2021 | 17 | 0.050 |
Why?
| | Seroconversion | 1 | 2021 | 46 | 0.040 |
Why?
| | Pepsinogen A | 1 | 2020 | 3 | 0.040 |
Why?
| | Predictive Value of Tests | 3 | 2012 | 2039 | 0.040 |
Why?
| | Gastroscopy | 1 | 2020 | 19 | 0.040 |
Why?
| | Risk Factors | 3 | 2012 | 10356 | 0.040 |
Why?
| | Gastric Mucosa | 1 | 2020 | 55 | 0.040 |
Why?
| | Signal Transduction | 2 | 2004 | 5096 | 0.040 |
Why?
| | Crosses, Genetic | 2 | 1990 | 137 | 0.040 |
Why?
| | Family Health | 2 | 2011 | 200 | 0.040 |
Why?
| | Stomach Diseases | 1 | 2018 | 20 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2006 | 2482 | 0.040 |
Why?
| | Base Sequence | 3 | 1993 | 2180 | 0.040 |
Why?
| | Thyroid Diseases | 1 | 2018 | 36 | 0.040 |
Why?
| | Family | 2 | 2013 | 667 | 0.040 |
Why?
| | Glycine | 1 | 2019 | 175 | 0.040 |
Why?
| | Mice, Inbred C57BL | 1 | 2008 | 5792 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2004 | 437 | 0.030 |
Why?
| | Blood Cell Count | 1 | 2017 | 54 | 0.030 |
Why?
| | Molecular Sequence Data | 3 | 1993 | 2901 | 0.030 |
Why?
| | United Kingdom | 1 | 2018 | 324 | 0.030 |
Why?
| | Biopsy | 1 | 2020 | 1132 | 0.030 |
Why?
| | Vitamin B 12 | 1 | 2017 | 126 | 0.030 |
Why?
| | Proteomics | 1 | 2022 | 1113 | 0.030 |
Why?
| | Prospective Studies | 2 | 2020 | 7598 | 0.030 |
Why?
| | Celiac Disease | 1 | 2018 | 293 | 0.030 |
Why?
| | Iron | 1 | 2017 | 313 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 2 | 2009 | 665 | 0.030 |
Why?
| | Culture Media, Serum-Free | 2 | 2004 | 48 | 0.030 |
Why?
| | Cameroon | 1 | 2013 | 9 | 0.030 |
Why?
| | Chromosomes, Human, Pair 14 | 1 | 1993 | 21 | 0.030 |
Why?
| | Carotid Artery Injuries | 2 | 2004 | 41 | 0.030 |
Why?
| | Transferases | 1 | 1993 | 33 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2857 | 0.030 |
Why?
| | Chromosomes, Human, Pair 8 | 1 | 1993 | 36 | 0.030 |
Why?
| | Oligonucleotides, Antisense | 2 | 2004 | 111 | 0.030 |
Why?
| | Alkyl and Aryl Transferases | 1 | 1993 | 53 | 0.030 |
Why?
| | Catheterization | 2 | 2004 | 179 | 0.030 |
Why?
| | Risk Assessment | 2 | 2013 | 3439 | 0.030 |
Why?
| | S100 Calcium Binding Protein beta Subunit | 1 | 2012 | 8 | 0.030 |
Why?
| | S100 Proteins | 1 | 2012 | 37 | 0.020 |
Why?
| | Luminescent Measurements | 1 | 2013 | 76 | 0.020 |
Why?
| | HLA-B15 Antigen | 1 | 2012 | 13 | 0.020 |
Why?
| | HLA-B8 Antigen | 1 | 2012 | 14 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2019 | 1458 | 0.020 |
Why?
| | Nerve Growth Factors | 1 | 2012 | 80 | 0.020 |
Why?
| | Addison Disease | 1 | 2012 | 43 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2021 | 5139 | 0.020 |
Why?
| | Potassium Channels | 1 | 2012 | 153 | 0.020 |
Why?
| | Adenosine Triphosphatases | 1 | 2012 | 167 | 0.020 |
Why?
| | Enzyme-Linked Immunospot Assay | 1 | 2011 | 36 | 0.020 |
Why?
| | International Cooperation | 1 | 2011 | 198 | 0.020 |
Why?
| | Restriction Mapping | 1 | 1990 | 76 | 0.020 |
Why?
| | Base Composition | 1 | 1990 | 77 | 0.020 |
Why?
| | Glucose Tolerance Test | 1 | 2012 | 361 | 0.020 |
Why?
| | DNA, Fungal | 1 | 1990 | 79 | 0.020 |
Why?
| | Risk | 1 | 2013 | 905 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2011 | 690 | 0.020 |
Why?
| | ROC Curve | 1 | 2011 | 547 | 0.020 |
Why?
| | C-Peptide | 1 | 2010 | 163 | 0.020 |
Why?
| | Phosphorylation | 2 | 2004 | 1762 | 0.020 |
Why?
| | Sequence Homology | 1 | 2008 | 40 | 0.020 |
Why?
| | Cross Reactions | 1 | 2008 | 133 | 0.020 |
Why?
| | Japan | 1 | 2008 | 116 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 7593 | 0.020 |
Why?
| | Sex Factors | 1 | 2014 | 2074 | 0.020 |
Why?
| | Rats | 3 | 2004 | 5676 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 2 | 2004 | 2501 | 0.020 |
Why?
| | Multigene Family | 1 | 2008 | 202 | 0.020 |
Why?
| | Plasmids | 1 | 1989 | 363 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2011 | 790 | 0.020 |
Why?
| | Drosophila | 1 | 2008 | 146 | 0.020 |
Why?
| | Caenorhabditis elegans | 1 | 2008 | 307 | 0.010 |
Why?
| | Registries | 1 | 2013 | 2021 | 0.010 |
Why?
| | Chromones | 1 | 2004 | 44 | 0.010 |
Why?
| | Age Factors | 1 | 2011 | 3301 | 0.010 |
Why?
| | Basement Membrane | 1 | 2003 | 34 | 0.010 |
Why?
| | Focal Adhesion Kinase 1 | 1 | 2003 | 32 | 0.010 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 1 | 2003 | 34 | 0.010 |
Why?
| | Heparitin Sulfate | 1 | 2003 | 50 | 0.010 |
Why?
| | Androstadienes | 1 | 2004 | 107 | 0.010 |
Why?
| | Glycosaminoglycans | 1 | 2003 | 84 | 0.010 |
Why?
| | Morpholines | 1 | 2004 | 126 | 0.010 |
Why?
| | Fibronectins | 1 | 2003 | 133 | 0.010 |
Why?
| | PTEN Phosphohydrolase | 1 | 2004 | 162 | 0.010 |
Why?
| | Blood Glucose | 1 | 2013 | 2183 | 0.010 |
Why?
| | Sirolimus | 1 | 2004 | 275 | 0.010 |
Why?
| | Cattle | 1 | 2004 | 982 | 0.010 |
Why?
| | DNA Replication | 1 | 2003 | 242 | 0.010 |
Why?
| | Aorta | 1 | 2004 | 421 | 0.010 |
Why?
| | Aorta, Thoracic | 1 | 2003 | 267 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2004 | 845 | 0.010 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2003 | 434 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2015 | 10821 | 0.010 |
Why?
| | Pulmonary Artery | 1 | 2004 | 1083 | 0.010 |
Why?
| | Protein Kinase Inhibitors | 1 | 2004 | 920 | 0.010 |
Why?
| | Mutation | 1 | 2008 | 3964 | 0.010 |
Why?
| | Phenotype | 1 | 2004 | 3205 | 0.010 |
Why?
| | Farnesyltranstransferase | 1 | 1993 | 35 | 0.010 |
Why?
| | Hybrid Cells | 1 | 1993 | 49 | 0.010 |
Why?
| | Blotting, Southern | 1 | 1993 | 72 | 0.010 |
Why?
| | Cricetulus | 1 | 1993 | 110 | 0.010 |
Why?
| | Cricetinae | 1 | 1993 | 288 | 0.010 |
Why?
| | DNA, Complementary | 1 | 1993 | 269 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1993 | 536 | 0.010 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 1993 | 319 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 1993 | 523 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1993 | 2146 | 0.000 |
Why?
|
|
Wenzlau's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|